Search research articles
Contact Us
Filters
Showing results (471-480 of 736) with videos related to
Page
of 74
Sort By:
Journal of Medicinal Chemistry
|
April 29, 2005
Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands
Ke Ding, Jianyong Chen, Min Ji, et al.
Carbohydrate Polymers
|
July 24, 2024
Citrus oil gland and cuticular wax inspired multifunctional gelatin film of OSA-starch nanoparticles-based nanoemulsions for preserving perishable fruit
Ying Xie, Ke Ding, Saiqing Xu, et al.
European Journal of Pharmacology
|
June 8, 2024
Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive review
Wujun Geng, Holly Thomas, Zhiyuan Chen, et al.
Cancer Medicine
|
March 14, 2018
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR<sup>L858R, T790M</sup> -mutant resistance in vitro and in vivo
Zhang Zhang, Jian Zou, Lei Yu, et al.
European Journal of Medicinal Chemistry
|
February 8, 2019
Quinolone antibiotic derivatives as new selective Axl kinase inhibitors
Li Tan, Zhang Zhang, Donglin Gao, et al.
Journal of Medicinal Chemistry
|
January 6, 2016
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation
Xiaoqian Xue, Yan Zhang, Zhaoxuan Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2014
New benzimidazole-2-urea derivates as tubulin inhibitors
Wenna Wang, Dexin Kong, Huimin Cheng, et al.
Cell Reports Methods
|
July 11, 2025
Graft-seq precisely maps RNA modifications via site-specific chemical grafting strategy
Ting Li, Ke Ding, Ziming Bao, et al.
European Journal of Medicinal Chemistry
|
May 8, 2024
Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
Huiqiong Li, Ran Ke, Yang Zhou, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor
Yulin Mao, Meiying Zhang, Hao Tang, et al.
Page
of 74
Search research articles
Search
Showing results (471-480 of 736) with videos related to
Sort By:
Page
of 74
Journal of Medicinal Chemistry
|
April 29, 2005
Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands
Ke Ding, Jianyong Chen, Min Ji, et al.
Carbohydrate Polymers
|
July 24, 2024
Citrus oil gland and cuticular wax inspired multifunctional gelatin film of OSA-starch nanoparticles-based nanoemulsions for preserving perishable fruit
Ying Xie, Ke Ding, Saiqing Xu, et al.
European Journal of Pharmacology
|
June 8, 2024
Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive review
Wujun Geng, Holly Thomas, Zhiyuan Chen, et al.
Cancer Medicine
|
March 14, 2018
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR<sup>L858R, T790M</sup> -mutant resistance in vitro and in vivo
Zhang Zhang, Jian Zou, Lei Yu, et al.
European Journal of Medicinal Chemistry
|
February 8, 2019
Quinolone antibiotic derivatives as new selective Axl kinase inhibitors
Li Tan, Zhang Zhang, Donglin Gao, et al.
Journal of Medicinal Chemistry
|
January 6, 2016
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation
Xiaoqian Xue, Yan Zhang, Zhaoxuan Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2014
New benzimidazole-2-urea derivates as tubulin inhibitors
Wenna Wang, Dexin Kong, Huimin Cheng, et al.
Cell Reports Methods
|
July 11, 2025
Graft-seq precisely maps RNA modifications via site-specific chemical grafting strategy
Ting Li, Ke Ding, Ziming Bao, et al.
European Journal of Medicinal Chemistry
|
May 8, 2024
Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
Huiqiong Li, Ran Ke, Yang Zhou, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor
Yulin Mao, Meiying Zhang, Hao Tang, et al.
Page
of 74